Iniparib, also known as BSI-201, is a small-molecule prodrug inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP-1) with potential chemosensitizing, radiosensitizing and antineoplastic activities. In vivo, PARP-1 inhibitor BSI-201 is converted to the active drug, which selectively binds to PARP-1 and inhibits PARP-1- mediated DNA repair. Consequently, this agent may enhance the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapy and radiation therapy. In addition, PARP-1 inhibitor BSI-201 may exhibit direct antineoplastic activity against cancers defective in DNA repair.
仅供研究使用。 我们不向患者出售。
化学信息
名称 | Iniparib |
Iupac 化学名称 | 4-iodo-3-nitrobenzamide |
同义词 | BSI-201; BSI201 |
英文同义词 | BSI-201; BSI201 |
分子式 | C7H5IN2O3 |
分子量 | 292.03067 |
Smile | IC1=C(C=C(C(=O)N)C=C1)[N+](=O)[O-] |
InChiKey | MDOJTZQKHMAPBK-UHFFFAOYSA-N |
InChi | InChI=1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11) |
Cas号 | 160003-66-7 |
相关CAS号 | |
外观性状 | Solid powder |
纯度 | 98% by HPLC |
存储 | -20 ºC for 3 years |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |